Crestchem Limited (BOM:526269)
93.86
+3.86 (4.29%)
At close: Feb 12, 2026
Crestchem Market Cap
Crestchem has a market cap or net worth of 284.46 million as of February 13, 2026. Its market cap has decreased by -64.06% in one year.
Market Cap
284.46M
Enterprise Value
274.00M
Revenue
242.52M
Ranking
n/a
PE Ratio
14.05
Stock Price
93.86
Market Cap Chart
Since November 1, 2012, Crestchem's market cap has increased from 31.23M to 284.46M, an increase of 810.85%. That is a compound annual growth rate of 18.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 281.58M | -16.53% |
| Dec 31, 2025 | 337.35M | -59.85% |
| Dec 31, 2024 | 840.15M | 239.45% |
| Dec 29, 2023 | 247.50M | 38.66% |
| Dec 30, 2022 | 178.50M | 35.69% |
| Dec 31, 2021 | 131.55M | -13.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tyche Industries | 1.33B |
| Krebs Biochemicals & Industries | 1.28B |
| Accretion Nutraveda | 1.18B |
| Resonance Specialties | 1.18B |
| Bacil Pharma | 616.75M |
| Vasundhara Rasayans | 454.16M |
| Supha Pharmachem | 362.88M |
| Ishita Drugs and Industries | 223.82M |